Blue Square Asset Management, LLC Amgen Inc Transaction History

Blue Square Asset Management, LLC

$208 Million
Q2 2025

A detailed history of Blue Square Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Blue Square Asset Management, LLC holds 15,309 shares of AMGN stock, worth $4.36 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares

15,309

Previous 14,068 8.82%

Holding current value

$4.36 Million

Previous $4.38 Million 2.46%

% of portfolio

2.05%

Previous 2.42%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	BUY	$262.28 - $309.85 $325,489 - $384,523	1,241 Added 8.82%	15,309 $4.27 Million
Q1 2025 May 01, 2025	SELL	$258.59 - $327.36 $52,493 - $66,454	-203 Reduced 1.42%	14,068 $4.38 Million
Q4 2024 Jan 21, 2025	BUY	$258.78 - $328.31 $1.88 Million - $2.39 Million	7,277 Added 104.05%	14,271 $3.72 Million
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $38,981 - $42,509	126 Added 1.83%	6,994 $2.25 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $70,417 - $85,575	268 Added 4.06%	6,868 $2.15 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $5,915 - $7,140	-22 Reduced 0.33%	6,600 $1.88 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $354,655 - $400,094	1,387 Added 26.49%	6,622 $1.91 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $265,878 - $330,095	1,216 Added 30.26%	5,235 $1.41 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $514,462 - $608,341	2,401 Added 148.39%	4,019 $892,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $365,328 - $445,273	1,618 New	1,618 $391,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $609,535 - $678,307	-2,642 Reduced 39.0%	4,133 $1.01 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $8,112 - $8,975	-37 Reduced 0.54%	6,775 $1.64 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $11,336 - $12,973	57 Added 0.84%	6,812 $1.53 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $32,477 - $38,051	153 Added 2.32%	6,755 $1.44 Million
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $159,768 - $177,251	684 Added 11.56%	6,602 $1.61 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $55,477 - $64,650	250 Added 4.41%	5,918 $1.47 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $399,870 - $476,174	-1,848 Reduced 24.59%	5,668 $1.3 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $330,152 - $367,156	1,407 Added 23.03%	7,516 $1.91 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $249,240 - $305,852	-1,260 Reduced 17.1%	6,109 $1.44 Million
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $3,098 - $4,108	17 Added 0.23%	7,369 $1.49 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $636,502 - $818,124	-3,364 Reduced 31.39%	7,352 $1.77 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $1.87 Million - $2.24 Million	10,716 New	10,716 $2.07 Million

Others Institutions Holding AMGN

# of Institutions

3,277

Shares Held

427M

Call Options Held

7.33M

Put Options Held

7.41M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Square Asset Management, LLC with notifications on news.

Account

Blue Square Asset Management, LLC Amgen Inc Transaction History